Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of M0002 in cirrhotic subjects with ascites and hyponatremia or normonatremia
2007-001711-31Phase 2Completed
- Sponsor
- Movetis
- Start
- May 2007
- Modality
- Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cirrhosis, ascites and hyponatraemia comparing M0002 dose-titration with Placebo (2 arms). Primary endpoints: Safety and tolerability of M0002, Pharmacokinetics of M0002 and 1 more. Started May 2007; status: completed.
02
Drugs
M0002
03
Conditions
Cirrhosisasciteshyponatraemia
Beyond the preview
Go deeper on 2007-001711-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001711-31.